Author: Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care, eases healthcare strain, says GlobalData. A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to benefit around 1,000 women annually, the pill offers a more convenient, effective treatment option. The National Health Service (NHS) in England has approved […]

Read More… from NHS approval of endometriosis therapy Ryeqo enhances patient care

NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver diseases such as primary sclerosing cholangitis (PSC) and is being tested in clinical studies. As PSC is often associated and potentially causally linked with chronic inflammatory bowel disease, a MedUni Vienna research team, jointly led […]

Read More… from Focus on the gut-liver axis

The British Dental Association has welcomed the rollout of fluoridation in the North East – alongside supervised brushing nationwide – but stressed these policies while effective have been needed for decades, and the delays they have faced reflect the lack of priority placed on oral health among successive governments and especially at the Treasury. Both […]

Read More… from Water fluoridation: Something to smile about

Researchers found that adding a deadline to bowel screening invitation letters boosted test returns, with the largest effect for a 2-week return deadline. The study, which was led by Professor Katie Robb from the University of Glasgow’s School of Health and Wellbeing, involved 40,000 adults in the nationwide Scottish Bowel Screening Programme. Screening by self-sampled […]

Read More… from Bowel screening uptake boosted

On Friday, 14th March Members of Parliament will meet to debate the Rare Cancers Bill, a Private Members’ Bill presented by Dr Scott Arthur MP (Labour, Edinburgh South West). The law change would implement key measures to address the left behind group of cancers called “rare cancers”. While each cancer may be rare, in aggregate […]

Read More… from MPs to debate Rare Cancers Bill